Vaccines provide a front-line defense against dangerous viruses, training adaptive immune cells to identify and fight specific pathogens. But innate immune cells—the first responders to any bodily ...
Vandria SA has announced a series A financing round raising $20.6 million (CHF18 million) to help advance its pipeline of first-in-class small-molecule mitophagy inducers.
Researchers have built a series of CRISPR-based platforms that can switch endogenous genes on and, just as critically, dial the activation level up or down by adjusting a small-molecule dose. The work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results